Stada Grabs GSK Brands In EU
German Generics Giant Becomes Major Consumer Healthcare Player
Executive Summary
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.
You may also be interested in...
Deal Watch: Genentech Sees Bicycle As Route To Novel Targeted Cancer Immunotherapies
Genentech pays $30m up front in a collaboration with Bicycle in a deal that could bring the UK biotech roughly $1.7bn in total. Also, deals involving Nimble, Seattle Genetics, Five Prime, Fresenius, Vifor, Yuhan, Imnewrun, Paratek, Almirall, MBD, AzothBio, Norgine, Faes, Aspen Pharmacare, Swixx.
GSK Offloads Physiogel In North America, Asia To Korea’s LG
GSK will raise around £125m from the sale of skin-care brand Physiogel to LG Household & Healthcare to finance the integration of Pfizer Consumer Healthcare.
Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player
Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: